Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
AIDS and Behavior
Published in: AIDS and Behavior 4/2011

01-05-2011 | Original Paper

Linkage to HIV Care and Survival Following Inpatient HIV Counseling and Testing

Authors: Rhoda K. Wanyenze, Judith A. Hahn, Cheryl A. Liechty, Kathie Ragland, Allan Ronald, Harriet Mayanja-Kizza, Thomas Coates, Moses R. Kamya, David R. Bangsberg

Published in: AIDS and Behavior | Issue 4/2011

Login to get access

Abstract

Linkage to HIV care and survival in sub-Saharan Africa is not well documented. In 2004 we conducted a randomized trial among medical inpatients in Mulago Hospital to assess the impact of HIV counseling and testing (HCT) on linkage to care and survival. Participants were randomized to inpatient HCT (intervention) or outpatient HCT 1 week post-discharge (control); inpatient HCT was not available at Mulago during the study. Among 590 eligible patients, 85% (500) agreed to participate; 98.8% (248) in the intervention arm received HCT compared to 68.7% (171) in the control arm. Within 6 months, 62.2% (92) of surviving HIV-infected participants received HIV care; 15.0% (20) received antiretroviral medications (ARVs). Overall mortality among HIV-infected participants was 34.6% (72). HCT had significant impact on linkage to care among surviving participants. Referral for HCT was a missed opportunity for diagnosis. There is need for earlier diagnosis and linkage to HIV care among inpatients.
Literature
1.
Allen S, Tice J, Van de Perre P, Serufilira A, Hudes E, Nsengumuremyi F, et al. Effect of serotesting with counselling on condom use and seroconversion among HIV discordant couples in Africa. BMJ. 1992;304(6842):1605–9.PubMedCrossRef
2.
Kamenga M, Ryder RW, Jingu M, Mbuyi N, Mbu L, Behets F, et al. Evidence of marked sexual behavior change associated with low HIV-1 seroconversion in 149 married couples with discordant HIV-1 serostatus: experience at an HIV counselling center in Zaire. AIDS. 1991;5(1):61–7.PubMedCrossRef
3.
Efficacy of voluntary HIV-1 counselling and testing in individuals and couples in Kenya, Tanzania, and Trinidad: a randomised trial. The Voluntary HIV-1 Counseling and Testing Efficacy Study Group. Lancet 2000 Jul 8;356(9224):103–12.
4.
Gresenguet G, Sehonou J, Bassirou B, Longo Jde D, Malkin JE, Brogan T, et al. Voluntary HIV counseling and testing: experience among the sexually active population in Bangui, Central African Republic. J Acquir Immune Defic Syndr. 2002;31(1):106–14.PubMedCrossRef
5.
UNAIDS. 2008 Report on the global AIDS epidemic. Geneva, Switzerland: Joint United Nations Program on HIV/AIDS (UNAIDS)2008.
6.
Lie GT, Biswalo PM, Klepp KI. Counseling and HIV-testing among hospital patients in Arusha and Kilimanjaro. Tidsskr Nor Laegeforen. 1995;115(26):3286–8.PubMed
7.
Kwesigabo G, Killewo JZ, Sandstrom A, Winani S, Mhalu FS, Biberfeld G, et al. Prevalence of HIV infection among hospital patients in north west Tanzania. AIDS Care. 1999;11(1):87–93.PubMedCrossRef
8.
Palmer DL, Mason PR, Pasi C, Tobiwa O. Value of mandatory testing for human immunodeficiency virus in a sub-Saharan hospital population. Clin Infect Dis. 2000;31(5):1258–65.PubMedCrossRef
9.
Wanyenze RK, Nawavvu C, Namale AS, Mayanja B, Bunnell R, Abang B, et al. Acceptability of routine HIV counselling and testing, and HIV seroprevalence in Ugandan hospitals. Bull World Health Organ. 2008;86(4):302–9.PubMedCrossRef
10.
Tembo G, Friesan H, Asiimwe-Okiror G, Moser R, Naamara W, Bakyaita N, et al. Bed occupancy due to HIV/AIDS in an urban hospital medical ward in Uganda. AIDS. 1994;8(8):1169–71.PubMedCrossRef
11.
Fabiani M, Accorsi S, Aleni R, Rizzardini G, Nattabi B, Gabrielli A, et al. Estimating HIV prevalence and the impact of HIV/AIDS on a Ugandan hospital by combining serosurvey data and hospital discharge records. J Acquir Immune Defic Syndr. 2003;34(1):62–6.PubMedCrossRef
12.
Wanyenze R, Kamya M, Liechty CA, Ronald A, Guzman DJ, Wabwire-Mangen F, et al. HIV counseling and testing practices at an urban hospital in Kampala, Uganda. AIDS Behav. 2006;10(4):361–7.PubMedCrossRef
13.
Centers for Disease Control and Prevention (CDC). Revised Recommendations for HIV Testing of Adults Adolescents and Pregnant Women in Health-Care Settings. MMWR Recomm Rep. 2006;55(RR-14):1–14.
14.
World Health Organisation (WHO). Guidance on provider-initiated HIV testing and counseling in health facilities. Geneva 2007.
15.
Uganda MOH. Uganda National Policy on HIV Counseling and Testing, September 2005. Kampala, Uganda: Ministry of Health; 2005.
16.
Nakanjako D, Kyabayinze DJ, Mayanja-Kizza H, Katabira E, Kamya MR. Eligibility for HIV/AIDS treatment among adults in a medical emergency setting at an urban hospital in Uganda. Afr Health Sci. 2007;7(3):124–8.PubMed
17.
Yu JK, Chen SC, Wang KY, Chang CS, Makombe SD, Schouten EJ, et al. True outcomes for patients on antiretroviral therapy who are “lost to follow-up” in Malawi. Bull World Health Organ. 2007;85(7):550–4.PubMedCrossRef
18.
Brinkhof MW, Dabis F, Myer L, Bangsberg DR, Boulle A, Nash D, et al. Early loss of HIV-infected patients on potent antiretroviral therapy programmes in lower-income countries. Bull World Health Organ. 2008;86(7):559–67.PubMedCrossRef
19.
Rennie S, Behets F. Desperately seeking targets: the ethics of routine HIV testing in low-income countries. Bull World Health Organ. 2006;84(1):52–7.PubMedCrossRef
20.
Uganda AIDS Commission (UAC). Report on Implementation of National HIV and AIDS Strategic Plan—FY 2007/2008, October 2008. Kampala, Uganda: Uganda AIDS Commission; 2008.
21.
Centers for Disease C, Prevention. Revised guidelines for HIV counseling, testing, and referral. MMWR Recomm Rep 2001 Nov 9;50(RR-19):1–57; quiz CE1-19a1-CE6-a1.
22.
Nakanjako D, Kamya M, Daniel K, Mayanja-Kizza H, Freers J, Whalen C, et al. Acceptance of routine testing for HIV among adult patients at the medical emergency unit at a national referral hospital in Kampala, Uganda. AIDS Behav. 2007;11(5):753–8.PubMedCrossRef
23.
Kigozi IM, Dobkin LM, Martin JN, Geng EH, Muyindike W, Emenyonu NI, et al. Late-Disease Stage at Presentation to an HIV Clinic in the Era of Free Antiretroviral Therapy in Sub-Saharan Africa. J Acquir Immune Defic Syndr 2009 Jun 10.
24.
Lawn SD, Harries AD, Anglaret X, Myer L, Wood R. Early mortality among adults accessing antiretroviral treatment programmes in sub-Saharan Africa. AIDS. 2008;22(15):1897–908.PubMedCrossRef
25.
Medley A, Garcia-Moreno C, McGill S, Maman S. Rates, barriers and outcomes of HIV serostatus disclosure among women in developing countries: implications for prevention of mother-to-child transmission programmes. Bull World Health Organ. 2004;82(4):299–307.PubMed
26.
Grinstead OA, Gregorich SE, Choi KH, Coates T. Positive and negative life events after counselling and testing: the Voluntary HIV-1 Counselling and Testing Efficacy Study. AIDS. 2001;15(8):1045–52.PubMedCrossRef
27.
Kiene SM, Bateganya M, Wanyenze R, Lule H, Nantaba H, Stein MD. Initial outcomes of provider-initiated routine HIV testing and counseling during outpatient care at a rural Ugandan hospital: risky sexual behavior, partner HIV testing, disclosure, and HIV care seeking. AIDS Patient Care STDS Feb;24(2):117–26.
28.
Menzies N, Abang B, Wanyenze R, Nuwaha F, Mugisha B, Coutinho A, et al. The costs and effectiveness of four HIV counseling and testing strategies in Uganda. AIDS. 2009;23(3):395–401.PubMedCrossRef
Metadata
Title
Linkage to HIV Care and Survival Following Inpatient HIV Counseling and Testing
Authors
Rhoda K. Wanyenze
Judith A. Hahn
Cheryl A. Liechty
Kathie Ragland
Allan Ronald
Harriet Mayanja-Kizza
Thomas Coates
Moses R. Kamya
David R. Bangsberg
Publication date
01-05-2011
Publisher
Springer US
Published in
AIDS and Behavior / Issue 4/2011
Print ISSN: 1090-7165
Electronic ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-010-9704-1

Other articles of this Issue 4/2011

AIDS and Behavior 4/2011 Go to the issue

Original Paper

Factors Associated with Refusal of Rapid HIV Testing in an Emergency Department

Original Paper

Provision of HIV Counseling and Testing Services at Five Community-Based Organizations Among Young Men of Color Who Have Sex with Men

Original Paper

A Surveillance Report of HIV Status and High Risk Behaviors Among Rapid Testing Participants in Tallinn, Estonia

Original Paper

People with HIV in HAART-Era Russia: Transmission Risk Behavior Prevalence, Antiretroviral Medication-Taking, and Psychosocial Distress

Original Paper

Patterns and Implications of Medical Pluralism Among HIV/AIDS Patients in Rural South Africa

ORIGINAL PAPER

Change in Sexual Activity 12 Months After ART Initiation Among HIV-Positive Mozambicans
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits